Vilacto Bio Inc. (fka VIBI)

[why_meil]

Raising the AS isn't a bad thing. It beats the alternative of VIBI closing up shop instead.

Raising the AS at least allows them to kick the can a little further down the road. It goes hand in hand with their toxic financing deals. But how else are they going to keep the lights on when revenues aren't sufficient to pay the bills?

Why do you think this is a penny stock in the first place? Not too many OTC companies that I can think of who don't have toxic financing arrangements. It comes with the territory when you're bottom feeding.

VIBI's debt certainly isn't triple A rated by Moody's. But then again their stock doesn't trade on the NYSE or NASDAQ either.